0000939798-20-000007.txt : 20200604 0000939798-20-000007.hdr.sgml : 20200604 20200604171528 ACCESSION NUMBER: 0000939798-20-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200602 FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cataldo Tony CENTRAL INDEX KEY: 0001450565 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 20943709 MAIL ADDRESS: STREET 1: C/O 475 INDUSTRIAL BLVD CITY: WEST CHICAGO STATE: IL ZIP: 60106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GT Biopharma, Inc. CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 310 N. WESTLAKE BLVD. STREET 2: SUITE 206 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: (800) 304-9888 MAIL ADDRESS: STREET 1: 310 N. WESTLAKE BLVD. STREET 2: SUITE 206 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 FORMER COMPANY: FORMER CONFORMED NAME: OXIS INTERNATIONAL INC DATE OF NAME CHANGE: 19940916 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-06-02 0 0000109657 GT Biopharma, Inc. GTBP 0001450565 Cataldo Tony 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 1 1 1 0 CEO common stock 2020-06-02 4 S 0 4234320 0.001 D 6500000 D The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018. /s/ Tony Cataldo 2020-06-04